Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Andrew Dickinson
Age : 50
Public asset : 2,690,822 USD
Country of residence : Unknown
Linked companies : Gilead Sciences, Inc. - Immunomedics, Inc. - Forty Seven, Inc.

Biography of Andrew Dickinson 
Mr. Andrew D. Dickinson is a President, Treasurer & Director at Immunomedics, Inc., a President, Treasurer & Director at Forty Seven, Inc. and a Chief Financial Officer at Gilead Sciences, Inc. He is on the Board of Directors at Immunomedics, Inc., Forty Seven, Inc., Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. Mr. Dickinson was previously employed as a Founding Partner by Kendall Dickinson & Koenig LLC, a Secretary, Vice President & General Counsel by Myogen, Inc., and a Co-Head-Healthcare Investment Banking by Lazard Ltd. He received his undergraduate degree from The University of Colorado and a graduate degree from Loyola University of Chicago.


Current positions of Andrew Dickinson 
Holdings of Andrew Dickinson 
Andrew Dickinson : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
More news


© 2021 People and Ownership :   
Andrew Dickinson : Connections 


Latest news about Andrew Dickinson 
2020GILEAD SCIENCES : cuts 2020 sales outlook as COVID-19 drug remdesivir falls short
RE
2020Gilead Quarterly Revenue Rises on Remdesivir Sales -- Update
DJ
2019Gilead Sciences, Inc. Appoints Andrew Dickinson as Chief Financial Officer, Effective November 1, 2019
CI
2018Gilead Sciences, Inc. Announces Executive Changes
CI
2017Gilead Sciences, Inc. completed the acquisition of Kite Pharma, Inc..
CI
2017Gilead Sciences, Inc. entered into a definitive agreement to acquire Kite Pharma, Inc. for $10.4 billion.
CI
More news